☰

Marc E. Mooney, Ph.D. - Publications

Affiliations: 
2003 University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
behavior genetics, brain, psychopathology
Tree Info Grants Similar researchers PubMed Report error

50 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Mooney ME, Schmitz JM, Allen S, Grabowski J, Pentel P, Oliver A, Hatsukami DK. Bupropion and Naltrexone for Smoking Cessation: A Double-Blind Randomized Placebo-Controlled Clinical Trial. Clinical Pharmacology and Therapeutics. PMID 27213949 DOI: 10.1002/Cpt.402  0.517
2015 Mooney ME, Herin DV, Specker S, Babb D, Levin FR, Grabowski J. Pilot study of the effects of lisdexamfetamine on cocaine use: A randomized, double-blind, placebo-controlled trial. Drug and Alcohol Dependence. 153: 94-103. PMID 26116930 DOI: 10.1016/J.Drugalcdep.2015.05.042  0.383
2015 Levin FR, Mariani JJ, Specker S, Mooney M, Mahony A, Brooks DJ, Babb D, Bai Y, Eberly LE, Nunes EV, Grabowski J. Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial. Jama Psychiatry. 72: 593-602. PMID 25887096 DOI: 10.1001/Jamapsychiatry.2015.41  0.363
2011 Kalman D, Herz L, Monti P, Kahler CW, Mooney M, Rodrigues S, O'Connor K. Incremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: Results from a randomized, double-blind, placebo-controlled study Drug and Alcohol Dependence. 118: 111-118. PMID 21507585 DOI: 10.1016/J.Drugalcdep.2011.03.005  0.527
2011 Sofuoglu M, Duffey D, Mooney ME. Varenicline increases smoking abstinence at 6 months to a year compared with placebo or bupropion; nausea is the most commonly reported adverse effect. Evidence-Based Medicine. 16: 113-4. PMID 21393304 DOI: 10.1136/Ebm1200  0.487
2011 Mooney ME, Johnson EO, Breslau N, Bierut LJ, Hatsukami DK. Cigarette smoking reduction and changes in nicotine dependence. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 13: 426-30. PMID 21367813 DOI: 10.1093/Ntr/Ntr019  0.528
2011 Mooney ME, Odlaug BL, Kim SW, Grant JE. Cigarette smoking status in pathological gamblers: association with impulsivity and cognitive flexibility. Drug and Alcohol Dependence. 117: 74-7. PMID 21296507 DOI: 10.1016/J.Drugalcdep.2010.12.017  0.493
2011 Sofuoglu M, Mooney M, Kosten T, Waters A, Hashimoto K. Minocycline attenuates subjective rewarding effects of dextroamphetamine in humans Psychopharmacology. 213: 61-68. PMID 20838775 DOI: 10.1007/S00213-010-2014-5  0.34
2011 Sofuoglu M, Mouratidis M, Mooney M. Progesterone improves cognitive performance and attenuates smoking urges in abstinent smokers. Psychoneuroendocrinology. 36: 123-32. PMID 20675057 DOI: 10.1016/J.Psyneuen.2010.07.005  0.528
2009 Schmitz JM, Mooney ME, Green CE, Lane SD, Steinberg JL, Swann AC, Moeller FG. Baseline neurocognitive profiles differentiate abstainers and non-abstainers in a cocaine clinical trial. Journal of Addictive Diseases. 28: 250-7. PMID 20155594 DOI: 10.1080/10550880903028502  0.357
2009 Sofuoglu M, Mooney ME. Cholinergic functioning in stimulant addiction: implications for medications development. Cns Drugs. 23: 939-952. PMID 19845415 DOI: 10.2165/11310920-000000000-00000  0.321
2009 Sofuoglu M, Mitchell E, Mooney ME. Progesterone effects on subjective and physiological responses to intravenous nicotine in male and female smokers Human Psychopharmacology-Clinical and Experimental. 24: 559-564. PMID 19743227 DOI: 10.1002/Hup.1055  0.526
2009 Sofuoglu M, Herman AI, Mooney M, Waters AJ. Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans. Psychopharmacology. 207: 153-62. PMID 19693492 DOI: 10.1007/S00213-009-1643-Z  0.486
2009 Allen AM, Mooney M, Chakraborty R, Allen SS. Circadian patterns of ad libitum smoking by menstrual phase. Human Psychopharmacology. 24: 503-6. PMID 19517420 DOI: 10.1002/Hup.1039  0.44
2009 Dickmann PJ, Mooney ME, Allen SS, Hanson K, Hatsukami DK. Nicotine withdrawal and craving in adolescents: effects of sex and hormonal contraceptive use. Addictive Behaviors. 34: 620-3. PMID 19398166 DOI: 10.1016/J.Addbeh.2009.03.033  0.388
2009 Sofuoglu M, Mooney ME. Subjective responses to intravenous nicotine: greater sensitivity in women than in men. Experimental and Clinical Psychopharmacology. 17: 63-69. PMID 19331482 DOI: 10.1037/A0015297  0.44
2009 Allen SS, Allen AM, Mooney M, Bade T. Short-term weight gain by menstrual phase following smoking cessation in women. Eating Behaviors. 10: 52-5. PMID 19171319 DOI: 10.1016/J.Eatbeh.2008.10.003  0.434
2009 Mooney ME, Herin DV, Schmitz JM, Moukaddam N, Green CE, Grabowski J. Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial. Drug and Alcohol Dependence. 101: 34-41. PMID 19058926 DOI: 10.1016/J.Drugalcdep.2008.10.016  0.361
2009 Sofuoglu M, Waters AJ, Mooney M, O'Malley SS. Minocycline reduced craving for cigarettes but did not affect smoking or intravenous nicotine responses in humans Pharmacology Biochemistry and Behavior. 92: 135-140. PMID 19041336 DOI: 10.1016/J.Pbb.2008.11.004  0.539
2009 Moukaddam N, Herin DV, Stotts A, Dougherty AH, Green C, Mooney M, Garcia A, Meisch RA, Cowan K, Moeller FG, Schmitz JM, Grabowski J. Comparison of 3 L-α-acetyl-methadol (LAAM) maintenance strategies for heroin dependence Addictive Disorders and Their Treatment. 8: 191-200. DOI: 10.1097/Adt.0B013E3181848B04  0.311
2008 Mooney ME, Poling J, Gonzalez G, Gonsai K, Kosten T, Sofuoglu M. Preliminary study of buprenorphine and bupropion for opioid-dependent smokers. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 17: 287-92. PMID 18612883 DOI: 10.1080/10550490802138814  0.441
2008 Mooney ME, Li ZZ, Murphy SE, Pentel PR, Le C, Hatsukami DK. Stability of the nicotine metabolite ratio in ad libitum and reducing smokers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 1396-400. PMID 18559554 DOI: 10.1158/1055-9965.Epi-08-0242  0.502
2008 Hoeppner BB, Goodwin MS, Velicer WF, Mooney ME, Hatsukami DK. Detecting longitudinal patterns of daily smoking following drastic cigarette reduction. Addictive Behaviors. 33: 623-39. PMID 18191907 DOI: 10.1016/J.Addbeh.2007.11.005  0.508
2008 Schmitz JM, Mooney ME, Moeller FG, Stotts AL, Green C, Grabowski J. Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform. Drug and Alcohol Dependence. 94: 142-50. PMID 18164144 DOI: 10.1016/J.Drugalcdep.2007.11.004  0.384
2008 Sofuoglu M, Waters AJ, Mooney M. Modafinil and nicotine interactions in abstinent smokers Human Psychopharmacology. 23: 21-30. PMID 17868195 DOI: 10.1002/Hup.878  0.506
2008 Sofuoglu M, Waters AJ, Mooney M, Kosten T. Riluzole and d-amphetamine interactions in humans Progress in Neuro-Psychopharmacology and Biological Psychiatry. 32: 16-22. PMID 17714844 DOI: 10.1016/J.Pnpbp.2007.05.003  0.308
2008 Mooney ME, Reus VI, Gorecki J, Hall SM, Humfleet GL, Muñoz RF, Delucchi K. Therapeutic drug monitoring of nortriptyline in smoking cessation: a multistudy analysis. Clinical Pharmacology and Therapeutics. 83: 436-42. PMID 17687275 DOI: 10.1038/Sj.Clpt.6100307  0.502
2008 Sofuoglu M, Yoo S, Hill KP, Mooney ME. Self-Administration of Intravenous Nicotine in Male and Female Cigarette Smokers Neuropsychopharmacology. 33: 715-720. PMID 17534380 DOI: 10.1038/Sj.Npp.1301460  0.466
2007 Hecht SS, Carmella SG, Murphy SE, Riley WT, Le C, Luo X, Mooney M, Hatsukami DK. Similar exposure to a tobacco-specific carcinogen in smokeless tobacco users and cigarette smokers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 1567-72. PMID 17684130 DOI: 10.1158/1055-9965.Epi-07-0227  0.471
2007 Schmitz JM, Stotts AL, Mooney ME, Delaune KA, Moeller GF. Bupropion and cognitive-behavioral therapy for smoking cessation in women. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 9: 699-709. PMID 17558827 DOI: 10.1080/14622200701365335  0.437
2007 Stotts AL, Mooney ME, Sayre SL, Novy M, Schmitz JM, Grabowski J. Illusory predictors: Generalizability of findings in cocaine treatment retention research. Addictive Behaviors. 32: 2819-36. PMID 17543472 DOI: 10.1016/J.Addbeh.2007.04.020  0.329
2007 Hatsukami D, Mooney M, Murphy S, LeSage M, Babb D, Hecht S. Effects of high dose transdermal nicotine replacement in cigarette smokers Pharmacology Biochemistry and Behavior. 86: 132-139. PMID 17267026 DOI: 10.1016/J.Pbb.2006.12.017  0.524
2007 Mooney ME, Schmitz JM, Moeller FG, Grabowski J. Safety, tolerability and efficacy of levodopa-carbidopa treatment for cocaine dependence: two double-blind, randomized, clinical trials. Drug and Alcohol Dependence. 88: 214-23. PMID 17134849 DOI: 10.1016/J.Drugalcdep.2006.10.011  0.357
2007 Mooney ME, Sayre SL, Hokanson PS, Stotts AL, Schmitz JM. Adding MEMS feedback to behavioral smoking cessation therapy increases compliance with bupropion: a replication and extension study. Addictive Behaviors. 32: 875-80. PMID 16839698 DOI: 10.1016/J.Addbeh.2006.06.022  0.512
2007 Chawdhary A, Sayre SL, Green C, Schmitz JM, Grabowski J, Mooney ME. Moderators of delay tolerance in treatment-seeking cocaine users. Addictive Behaviors. 32: 370-6. PMID 16713126 DOI: 10.1016/J.Addbeh.2006.03.044  0.371
2006 Strasser AA, O'Connor RJ, Mooney ME, Wileyto EP. Digital image analysis of cigarette filter stains as an indicator of compensatory smoking. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 2565-9. PMID 17164388 DOI: 10.1158/1055-9965.Epi-06-0623  0.446
2006 Hatsukami DK, Le CT, Zhang Y, Joseph AM, Mooney ME, Carmella SG, Hecht SS. Toxicant exposure in cigarette reducers versus light smokers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 2355-8. PMID 17164356 DOI: 10.1158/1055-9965.Epi-06-0240  0.461
2006 Mooney ME, Green C, Hatsukami DK. Nicotine self‐administration: cigarette versus nicotine gum diurnal topography Human Psychopharmacology-Clinical and Experimental. 21: 539-548. PMID 17066490 DOI: 10.1002/Hup.808  0.53
2006 Leventhal AM, Mooney ME, DeLaune KA, Schmitz JM. Using addiction severity profiles to differentiate cocaine-dependent patients with and without comorbid major depression. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 15: 362-9. PMID 16966192 DOI: 10.1080/10550490600860148  0.306
2006 Mooney ME, Sofuoglu M. Bupropion for the treatment of nicotine withdrawal and craving. Expert Review of Neurotherapeutics. 6: 965-81. PMID 16831112 DOI: 10.1586/14737175.6.7.965  0.553
2006 Mooney ME, Leventhal AM, Hatsukami DK. Attitudes and knowledge about nicotine and nicotine replacement therapy. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 8: 435-46. PMID 16801301 DOI: 10.1080/14622200600670397  0.474
2006 Mooney M, Sofuoglu M, Dudish-Poulsen S, Hatsukami DK. Preliminary observations of paranoia in a human laboratory study of cocaine. Addictive Behaviors. 31: 1245-1251. PMID 16137832 DOI: 10.1016/J.Addbeh.2005.08.003  0.373
2005 Mooney M, Babb D, Jensen J, Hatsukami D. Interventions to increase use of nicotine gum: A randomized, controlled, single-blind trial Nicotine and Tobacco Research. 7: 565-580. PMID 16085528 DOI: 10.1080/14622200500185637  0.495
2005 Schmitz JM, Sayre SL, Stotts AL, Rothfleisch J, Mooney ME. Medication compliance during a smoking cessation clinical trial: a brief intervention using MEMS feedback. Journal of Behavioral Medicine. 28: 139-47. PMID 15957569 DOI: 10.1007/S10865-005-3663-4  0.458
2005 Sofuoglu M, Dudish-Poulsen S, Poling J, Mooney ME, Hatsukami DK. The effect of individual cocaine withdrawal symptoms on outcomes in cocaine users Addictive Behaviors. 30: 1125-1134. PMID 15925122 DOI: 10.1016/J.Addbeh.2004.10.010  0.311
2004 Mooney ME, White T, Hatsukami DK. The blind spot in the nicotine replacement therapy literature: assessment of the double-blind in clinical trials. Addictive Behaviors. 29: 673-684. PMID 15135549 DOI: 10.1016/J.Addbeh.2004.02.010  0.416
2004 Lemmonds CA, Mooney M, Reich B, Hatsukami D. Characteristics of cigarette smokers seeking treatment for cessation versus reduction. Addictive Behaviors. 29: 357-64. PMID 14732424 DOI: 10.1016/J.Addbeh.2003.08.049  0.522
2004 Mooney M, Sayre S, Green C, Rhoades H, Schmitz J. Comparing Measures of Medication Taking in a Pharmacotherapy Trial for Cocaine Dependence Addictive Disorders & Their Treatment. 3: 165-173. DOI: 10.1097/01.Adt.0000132509.65041.Bf  0.328
2003 Hatsukami DK, Jensen J, Brauer LH, Mooney M, Schulte S, Sofuoglu M, Pentel PR. Lack of effect of 5HT3 antagonist in mediating subjective and behavioral responses to cotinine. Pharmacology, Biochemistry, and Behavior. 75: 1-7. PMID 12759107 DOI: 10.1016/S0091-3057(03)00035-2  0.448
1999 Hatsukami DK, Mooney ME. Pharmacological and Behavioral Strategies for Smoking Cessation Journal of Clinical Psychology in Medical Settings. 6: 11-38. DOI: 10.1023/A:1026251229992  0.501
Show low-probability matches.